XClose

UCL News

Home
Menu

UK's access to new drugs could be disrupted after Brexit

27 June 2017

Health and economics consultant, Anthony Hatswell (UCL PHD student in statistics), explains that access to novel treatments could be delayed if the UK leaves the European Medical Agency. Read: Independent, More: Wired, The Pharma Letter, Science Daily